Company: SHPH
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009325
Chunk: 33

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 4
Chunk 33
---
 Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
  
    31.2
     
    Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
  
    32.1
     
    Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
  
    32.2
     
    Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
  
    101.INS
     
    Inline XBRL Document Set for the financial statements and accompanying notes in Part
I, Item 1, of this Quarterly Report on Form 10-Q.
  
    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Filed herewith.

**Furnished herewith.

32

SIGNATURES

In accordance with the requirements
of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    SHUTTLE PHARMACEUTICALS HOLDINGS, INC.

    May 8, 2025
    By:
    /s/ Chris Cooper

    Chris Cooper

    Interim Chief Executive
    Officer

    (Principal Executive Officer)

    May 8, 2025
    By:
    /s/ Timothy J. Lorber

    Timothy J. Lorber
    Chief Financial Officer

    (Principal Financial and Accounting Officer)

33